Literature DB >> 11997879

Acetylcholine receptors and nerve terminal distribution at the neuromuscular junction of non-obese diabetic mice.

Maria Julia Marques1, Humberto Santo Neto.   

Abstract

Skeletal muscle is one of the main targets of the metabolic alterations in diabetes, in which protein synthesis is markedly reduced followed by increased proteolysis. Ultrastructural and functional changes in the presynaptic compartment of the neuromuscular junction (NMJ) have been demonstrated, but little attention has been paid to the proteins in the postsynaptic muscle fiber membrane. In the present work, we studied the changes in acetylcholine receptors (AChRs) and nerve terminal distribution in the NMJ of non-obese diabetic (NOD) mice. The sternomastoid muscles of adult female NOD mice were double-labeled for AChR and nerve terminal observation by fluorescence and reflected light confocal microscopy. In 62.4% of the diabetic endplates, AChR branches broke apart into receptor islands that stained less than in the normal mice. These patches had regular junctional folds. At most of the endplates studied, the nerve terminals colocalized with AChRs, and sprouts were seen in 10% of the diabetic endplates. The intramuscular nerve branches and axons in the nerve to the sternomastoid muscle showed no degenerative disorders. These results suggest that metabolic alterations in the diabetic muscle fiber can affect the distribution and expression of molecules, such as AChRs, in the postsynaptic membrane of the neuromuscular junction. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997879     DOI: 10.1002/ar.10091

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  4 in total

1.  Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.

Authors:  Carmen C Garcia; Joseph G Potian; Kormakur Hognason; Baskaran Thyagarajan; Lester G Sultatos; Nizar Souayah; Vanessa H Routh; Joseph J McArdle
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-26       Impact factor: 4.310

2.  Motor unit number estimate as a predictor of motor dysfunction in an animal model of type 1 diabetes.

Authors:  Nizar Souayah; Joseph G Potian; Carmen C Garcia; Natalia Krivitskaya; Christine Boone; Vanessa H Routh; Joseph J McArdle
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

3.  Streptozotocin diabetes attenuates the effects of nondepolarizing neuromuscular relaxants on rat muscles.

Authors:  Lina Huang; Dan Chen; Shitong Li
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

4.  In vivo injection of α-bungarotoxin to improve the efficiency of motor endplate labeling.

Authors:  Wentao Chen; Tingting Yu; Bo Chen; Yisong Qi; Peixun Zhang; Dan Zhu; Xiaofeng Yin; Baoguo Jiang
Journal:  Brain Behav       Date:  2016-04-27       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.